Cynosure
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Cynosure sits in the top decile of US sponsors by registered trial count (#380 of 15,742 sponsors by registered trial count).
Cynosure: 49 sponsored US clinical trials, 1 recruiting.
Cynosure sponsors 49 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 41 completed. The most-studied condition in this pipeline is Acne Scars, with 3 trials.
Top-decile sponsor footprint
Cynosure ranks in the top decile of sponsors by registered trial count (#380 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
41 of 47 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
49 total, page 1 of 1
Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions
NCT05987319
Clinical Study to Evaluate Alexandrite Laser for the Treatment of Acne Scars
NCT04807179
Pilot Evaluation of the Cynosure Potenza™ System for Treatment of Cosmetic Dermatologic Skin Conditions
NCT05847530
Prospective Clinical Study to Assess Safety and to Collect Data on Radiofrequency Microneedling Device(s) For the Purpose of Evaluating Treatment on Skin
NCT06023303
Study To Evaluate The Safety And Efficacy Of The MyEllevate® Procedure
NCT05590039
Clinical Study To Evaluate Paired Treatment With An Alexandrite Laser And Radiofrequency Microneedling For Facial Aging
NCT05388604
Study To Assess Radiofrequency Diathermocontraction Device For Muscle Stimulation And The Treatment Of Abdominal Fat
NCT05388617
Post Market Usability Evaluation Of The PicoSure Pro Device
NCT05102617
Feasibility Study To Collect Safety And Preliminary Efficacy Data For A Radiofrequency Microneedling Device
NCT05254210
Post Market Study To Collect Efficacy Data For The Treatment Of Wrinkles With A Radiofrequency Device
NCT05096247
Study To Assess The Safety And Efficacy Of The Tempsure Flexsure Applicators For Abdominal Wrinkles
NCT04930705
Post Market Clinical Follow Up Study to Collect Additional Data and Imaging
NCT04881058
Post Market Study Using The Elite IQ Device
NCT04807205
Post-Market Clinical Follow Up Study to Collect Additional Data and Imaging
NCT04880070
Histological Study to Assess Safety and Efficacy of the TempSure Firm for Non-Invasive Lipolysis
NCT04878172
Rollover Study to Evaluate Histological Results of Radiofrequency Device Treatments on the Flanks
NCT04881149
Histological Study on Safety and Efficacy of a RF Device Flexible Applicator for Non-Invasive Lipolysis
NCT04881175
Multi-Center Traditional Feasibility Study of Radiofrequency Device
NCT04584099
Multi-Center Pivotal Study of Radiofrequency Device
NCT04569253
Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions
NCT05097157
Clinical Study To Assess The Safety, Parameters And Efficacy For Procedures Using A Radiofrequency Device
NCT05166824
Study for the RevLite Laser System for Facial Solar Lentigines
NCT02110108
Picosure Alexandrite Laser and Revlite Nd:Yag Laser for the Treatment of Unwanted Tattoos
NCT02110121
Picosure Alexandrite Laser for the Treatment of Unwanted Tattoos
NCT02110095
A Study of the RevLite Laser System for the Treatment of Refractory Mixed Type Melasma
NCT02110134
The Smartlipo Triplex 1440nm Wavelength Laser and the Sidelaze 800 Hand Piece for the Treatment of Facial Acne Scars
NCT02103816
Clinical Evaluation of the Picosure Laser for the Treatment of Unwanted Tattoos
NCT02103153
Evaluating the Safety and Efficacy of the Pico Laser With a Specialized Lens Array for the Treatment of Wrinkles
NCT02091102
Evaluation of the Safety and Efficacy of the Pico Laser With a Specialized Lens Array for the Treatment of Wrinkles
NCT02091089
Evaluation of the Picosure 755nm Alexandrite Laser With Lens Array for the Treatment of Acne Scars
NCT02103127
Clinical and Histological Evaluation of the Picosure 755nm Laser With Cap Array for Facial Rejuvenation
NCT02107157
Evaluation of the Safety and Precursors of Efficacy
NCT02098811
Combination Alexandrite Laser and Topical Therapy vs Topical Therapy Alone for Treatment of Melasma
NCT02095756
Evaluation of 1440nm Laser Assisted Selective Photothermolysis for Treatment of Axillary Hyperhidrosis
NCT02100072
Evaluation of the 755nm Alexandrite for Unwanted Tattoos
NCT01842815
Evaluation of the 755nm Alexandrite for the Treatment of Epidermal and Dermal Pigmented Lesions
NCT01754233
Evaluation of the 755nm Alexandrite Laser for Skin Toning and Epidermal Pigmented Lesions in Asian Skin Types
NCT01754246
Clinical and Histological Evaluation of the 755nm Alexandrite Laser With Handpiece for the Treatment of Scars
NCT01813786
Treatment of Periorbital and Perioral Wrinkles With the Applications of the Iluminage Diode Laser
NCT01813760
Evaluation of 1440nm Laser vs. Botulinum Toxin or miraDry® Microwave For Treatment of Axillary Hyperhidrosis
NCT01811004
Mandible and Sub-mandible Using the 1440nm Wavelength Laser and Hand Piece
NCT01813747
Revlite Laser System Compared to the Candela Alex TriVantage System Refractory Mixed Type Melasma
NCT01745224
Evaluation of the 755nm Alexandrite Laser for the Treatment of Scars
NCT01811030
Investigation of Hyperhidrosis Treatment Using the Nd: YAG 1440nm Wavelength Laser
NCT01810991
Clinical Investigation of Non Invasive Fat Reduction
NCT01842802
755nm Alex Laser for Treatment of Stretch Marks
NCT01745211
Evaluation of the 755nm Alexandrite Laser for the Treatment of Tattoos
NCT01754207
755nm Alex Laser for Treatment of Pigmented and Vascular Lesions and Scars
NCT01745627
Laser Treatment for Fresh Surgical Scars and Mature Scars
NCT01030198
What is open in the Cynosure pipeline
1 recruiting of 49 indexed (2% open); 41 completed (84%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Acne Scars (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Cynosure: open-pipeline peers nationwide
Peers matched on 49 registered trials and 2% open enrollment, not the therapeutic-area sidebar.
Cynosure sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 49 trials (± recruiting share)
- Alnylam Pharmaceuticals · 49 trials · 29% recruiting
- argenx · 49 trials · 39% recruiting
- Braintree Laboratories · 49 trials · 0% recruiting
- Mirati Therapeutics · 49 trials · 10% recruiting
Sponsors near 2% open enrollment (± trial volume)
- Genzyme, a Sanofi Company · 2% recruiting · 196 trials
- Carelon Research · 2% recruiting · 50 trials
- Sun Pharmaceutical Industries · 2% recruiting · 48 trials
- Sanofi Pasteur, a Sanofi Company · 2% recruiting · 153 trials
Related
What to do with this Cynosure page
49 registered trials is a research-attention snapshot, not an endorsement of Cynosure or any single study.
- 1 of Cynosure's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Acne Scars is the condition Cynosure studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Acne Scars trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Cynosure pipeline card: 49 registered trials from official public datasets.Report a data error.